TOP2A and lymphoma: To investigate whether CX-5461 Pol I inhibitory activity could be modulated by the level of Top2α protein, we measured the effect of CX-5461 on the rate of rRNA synthesis in T2AWT and T2A+/K1266 lymphoma cells using metabolic labelling as described previously [6].